• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED Back to Search Results
Model Number BA28-90/I20-30
Device Problems Collapse (1099); Kinked (1339); Malposition of Device (2616)
Patient Problems Stenosis (2263); Claudication (2550)
Event Date 10/24/2016
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted in the patient.
 
Event Description
Patient was initially implanted with a bifurcated stent and an infrarenal aortic extension on (b)(6) 2016.Patient came in for follow up and had issues with their right and left leg, the physician diagnosed the patient with possible claudication.Computed tomography (ct) showed a potential narrowing in the limb of the bifurcated stent at the proximal common iliac artery.The physician elected to complete a secondary procedure and during the intervention the physician identified stenosis of the right common iliac artery (rcia).The physician completed a balloon angioplasty procedure to resolve the issue.The patient is in stable condition.
 
Manufacturer Narrative
At the completion of the complaint investigation, based on the information received, the following reported events were confirmed; bilateral claudication, narrowing of the proximal graft, a kink which was over-crowding of struts caused by the small aortic-iliac junction.Additionally there was evidence to reasonably support the following observations; bilateral reduction of renal vascular due to juxtarenal position of the infrarenal cuff and intentional sacrifice of the right accessory renal artery.The clinical evaluation additionally found evidence to reasonably suggest the following contributing factors to the reported event; off label use, existing peripheral occlusive disease, patent anatomy, continued tobacco use, positioning of the cuff, and intentional sacrifice of the right accessory renal artery.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.Devices remain implanted in the patient and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause at this time.There has been no additional adverse events reported for this patient.Correction: patient codes updated.Device codes updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
tahereh sedighi
2 musick
irvine, CA 92618
9495984671
MDR Report Key6123199
MDR Text Key60742370
Report Number2031527-2016-00551
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009012630
UDI-Public(01)00818009012630(17)180410
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/24/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/10/2018
Device Model NumberBA28-90/I20-30
Device Lot Number1251916-006
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/24/2016
Initial Date FDA Received11/22/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
INFRARENAL AORTO UNI-ILIAC- 1252540-029
Patient Outcome(s) Required Intervention;
-
-